Total Payments
$657.94
2024 Payments
$40.34
Companies
5
Transactions
12
Medicare Patients
1,773
Medicare Billing
$174,401
Payment Breakdown by Category
Food & Beverage$657.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $657.94 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $545.86 | 6 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $40.34 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.85 | 1 | $0 (2022) |
| Genentech USA, Inc. | $23.21 | 2 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $22.68 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.34 | 2 | Neurocrine Biosciences, Inc. ($40.34) |
| 2023 | $545.86 | 6 | ACADIA Pharmaceuticals Inc ($545.86) |
| 2022 | $48.53 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($25.85) |
| 2021 | $23.21 | 2 | Genentech USA, Inc. ($23.21) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Neuropsychiatry | ||||||
| 02/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Neuropsychiatry | ||||||
| 09/14/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/24/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $114.25 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/24/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $114.25 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/17/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $158.83 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/17/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $126.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/03/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/10/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Virology & Specialty Care | ||||||
| 02/05/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 544 | 1,953 | $201,605 | $109,881 |
| 2022 | 11 | 399 | 847 | $69,440 | $35,568 |
| 2021 | 15 | 640 | 1,132 | $51,273 | $22,301 |
| 2020 | 8 | 190 | 255 | $15,586 | $6,651 |
Total Patients
1,773
Total Services
4,187
Medicare Billing
$174,401
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 114 | 702 | $77,220 | $46,630 | 60.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 122 | 534 | $48,060 | $24,720 | 51.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 165 | 506 | $43,010 | $22,352 | 52.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 84 | 84 | $21,025 | $9,887 | 47.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 16 | 40 | $4,400 | $2,696 | 61.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 18 | 32 | $2,720 | $1,288 | 47.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 11 | 11 | $2,750 | $1,228 | 44.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 14 | 44 | $2,420 | $1,082 | 44.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 64 | 195 | $21,450 | $11,257 | 52.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 85 | 187 | $15,895 | $8,578 | 54.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 48 | 128 | $11,520 | $5,609 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 53 | $4,929 | $3,277 | 66.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 47 | 50 | $7,500 | $2,552 | 34.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 12 | 12 | $3,000 | $1,553 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $1,974 | $1,220 | 61.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,416 | $1,072 | 75.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 31 | 45 | $1,350 | $338.45 | 25.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 12 | 13 | $351.00 | $99.97 | 28.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 24 | 138 | $55.20 | $11.33 | 20.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 119 | 132 | $12,320 | $8,128 | 66.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 124 | 136 | $20,400 | $6,978 | 34.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $2,714 | $1,756 | 64.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 17 | $2,397 | $1,409 | 58.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 33 | 33 | $1,980 | $1,269 | 64.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 84 | 123 | $3,690 | $958.41 | 26.0% |
About Ashley Pauldin
Ashley Pauldin is a Family healthcare provider based in Gardendale, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2020. The National Provider Identifier (NPI) number assigned to this provider is 1407481559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Pauldin has received a total of $657.94 in payments from pharmaceutical and medical device companies, with $40.34 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($657.94).
As a Medicare-enrolled provider, Pauldin has provided services to 1,773 Medicare beneficiaries, totaling 4,187 services with total Medicare billing of $174,401. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Gardendale, AL
- Active Since 03/10/2020
- Last Updated 12/24/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1407481559
Products in Payments
- NUPLAZID (Drug) $545.86
- INGREZZA (Drug) $40.34
- TRINTELLIX (Drug) $25.85
- Xofluza (Drug) $23.21
- HETLIOZ (Drug) $22.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Gardendale
Mrs. Jennifer Morris
Family — Payments: $3,287
Family $3,287
Mrs. Ashley Cavender, Crnp, CRNP
Family — Payments: $1,604
Family $1,604
Emily Entrekin, Crnp, CRNP
Family — Payments: $1,117
Family $1,117
Erika Meadows
Family — Payments: $692.93
Family $692.93
Julia Nelms, Crnp, CRNP
Family — Payments: $648.62
Family $648.62
Judith Cooley, Crnp, CRNP
Family — Payments: $378.97
Family $378.97